Serve Robotics (SBOT) Prices 10M Share Offering at $4/sh, Uplists to Nasdaq Apr 18, 2024 05:59AM
Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV" Apr 17, 2024 09:57PM
Serve Robotics Inc. Common Stock to Be Quoted on OTCQB Under Ticker Symbol "SBOT" Mar 7, 2024 07:00AM
Stellar Biotechnologies Reports Second Quarter Financial Results May 8, 2019 07:45AM
Stellar Biotechnologies Reports First Quarter Financial Results Feb 5, 2019 04:20PM


Nov 30, 2018 07:30AM Stellar Biotechnologies Reports Fiscal Year 2018 Financial Results
Oct 31, 2018 07:30AM Stellar Biotechnologies to Present at BlueTech Summit
Sep 5, 2018 07:30AM Stellar Biotechnologies to Supply KLH to National Institutes of Health
Aug 28, 2018 07:30AM Stellar Biotechnologies to Present at H. C. Wainwright Global Investment Conference
Aug 8, 2018 07:45AM Stellar Biotechnologies Reports Third Quarter Financial Results
Jul 5, 2018 07:34AM Stellar Biotechnologies (SBOT) Provides Statement on Favorable Clinical Study Results
Jul 5, 2018 07:30AM Stellar Issues Statement on Favorable Clinical Study Results
Jun 21, 2018 07:30AM Stellar Reports Positive Research Results from KLH Glycosylation Study
May 24, 2018 07:30AM Stellar Achieves Robust Viral Clearance for Manufacturing Process
May 7, 2018 08:30AM Stellar Biotechnologies Reports Second Quarter Financial Results
Apr 27, 2018 04:30PM Stellar Biotechnologies Announces One-for-Seven Reverse Split
Mar 29, 2018 08:45AM Stellar Biotech Begins Scale-Up and Expansion Project at Port Facility
Feb 27, 2018 09:00AM Stellar Biotechnologies Appoints Bioprocess Expert to Lead Manufacturing
Feb 7, 2018 04:05PM Stellar Biotechnologies Reports First Quarter 2018 Financial Results
Jan 25, 2018 08:30AM Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors
Dec 1, 2017 08:00AM Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results
Nov 29, 2017 08:30AM Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference
Aug 9, 2017 04:05PM Stellar Biotechnologies Reports Third Quarter 2017 Financial Results
Jun 7, 2017 08:30AM Stellar Biotechnologies Expands Operations Team
May 31, 2017 08:15AM Stellar Biotechnologies to Present at Marcum Investor Conference
May 9, 2017 04:15PM Stellar Biotechnologies Reports Second Quarter 2017 Financial Results
Mar 13, 2017 04:58PM Stellar Biotechnologies (SBOT) to Sell 'Immunogen & Vaccine Technology' to Matrivax
Mar 13, 2017 04:55PM Stellar Biotechnologies and Matrivax Sign Agreement to Transfer Vaccine Technology
Mar 1, 2017 07:30AM Amaran Biotechnology Selects Stellar KLH for Cancer Vaccines
Feb 6, 2017 07:15PM Stellar Biotechnologies Reports First Quarter 2017 Financial Results
Feb 6, 2017 07:30AM Stellar Biotechnologies Congratulates Partner's Decision to Extend Drug Development for Diabetes
Jan 11, 2017 07:30AM Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region
Jan 4, 2017 07:30AM Stellar Biotechnologies to Present at Biotech Showcase Conference
Dec 14, 2016 04:05PM Stellar Biotechnologies Reports Fiscal Year 2016 Financial Results
Dec 12, 2016 07:45AM Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call
Dec 9, 2016 07:45AM Stellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors
Dec 1, 2016 07:45AM Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference
Oct 24, 2016 07:30AM Stellar Board Member and Pharma Expert to Join Executive Team
Oct 5, 2016 08:30AM Stellar Appoints Investor Relations Executive to Management Team to Support Its Continuing Scale-Up
Oct 4, 2016 07:00AM VistaGen Therapeutics Appoints Mark A. McPartland Vice President of Corporate Development and Investor Relations
Nov 4, 2015 10:00AM Stellar Biotechnologies, Inc. (Nasdaq:SBOT) to Ring The Nasdaq Stock Market Closing Bell
Nov 4, 2015 10:00AM Stellar Biotechnologies, Inc. (Nasdaq:SBOT) to Ring The Nasdaq Stock Market Closing Bell